Impact of comprehensive nursing on hand-foot syndrome caused by oral capecitabine in breast cancer patients

Shanshan He, Mi Wang, Liuliu Zhang, Ping Zhu, Jianmei Zhou, Zhiping Fang, Lingyun Shi

Abstract

This study examines the effects of comprehensive nursing care on hand-foot syndrome (HFS) in breast cancer patients treated with capecitabine. A retrospective analysis was conducted on 71 patients, divided into a study group receiving comprehensive care and a control group receiving conventional care. Results showed that the study group experienced significant improvements in skin symptoms, self-efficacy, quality of life, and lower anxiety and depression levels compared to the control group. Additionally, patients who were compliant with medications were notably better in the study group. Comprehensive care effectively alleviates the symptoms of hand-foot syndrome in breast cancer patients treated with capecitabine and enhances patient well-being

Full Text:

PDF

References

Kwakman JJM, Elshot YS, Punt CJA and Koopman M.

Management of cytotoxic chemotherapy-induced

hand-foot syndrome. Oncol Rev 2020; 14(1):442.

Urakawa R, Tarutani M, Kubota K and Uejima E. Hand Foot

Syndrome Has the Strongest Impact on QOL in Skin

Toxicities

of

Chemotherapy. Cancer 2019;

(20):4846-4851.

Kanbayashi Y, Taguchi T, Ishikawa T, Otsuji E and

Takayama K. Risk Factors of Capecitabine-Induced

Hand-Foot

Syndrome:

A

Single-Institution,

Retrospective Study. Oncology 2023; 101(7):407

Hsu YH, Shen WC, Wang CH, Lin YF and Chen SC. Hand

foot syndrome and its impact on daily activities in

breast cancer patients receiving docetaxel-based

chemotherapy. Eur J Oncol Nurs 2019; 43:101670.

Takemura M, Ikemura K, Yoshinami T, Toyozumi Y,

Shintani T, Ueda M, Shimazu K and Okuda M. Proton

Pump Inhibitors Ameliorate Capecitabine-induced

Hand-Foot Syndrome in Patients with Breast Cancer:

A Retrospective Study. Anticancer Res 2022;

(5):2591-2598.

Kewan T, Alomari M, Khazaaleh S, Covut F and Olayan M.

Hand-foot Syndrome Secondary to Low-dose

Docetaxel in a Breast Cancer Patient. Cureus 2019;

(4):e4400.

Zheng YF, Fu X, Wang XX, Sun XJ and He XD. Utility of

cooling patches to prevent hand-foot syndrome caused

by pegylated liposomal doxorubicin in breast cancer

patients. World J Clin Cases 2021; 9(33):10075

Hopman P, de Bruin SR, Forjaz MJ, Rodriguez-Blazquez C,

Tonnara G, Lemmens LC, Onder G, Baan CA and

Rijken M. Effectiveness of comprehensive care

programs for patients with multiple chronic conditions

or frailty: A systematic literature review. Health

Policy 2016;120(7):818-32.

Nagore E, Insa A and Sanmartín O. Antineoplastic therapy

induced palmar plantar erythrodysesthesia ('hand

foot')

syndrome. Incidence, recognition and

management. Am J Clin Dermatol 2000; 1(4):225-34.

Pandy JGP, Franco PIG and Li RK. Prophylactic strategies

for hand-foot syndrome/skin reaction associated with

systemic cancer treatment: a meta-analysis of

randomized controlled trials. Support Care Cancer

; 30(11):8655-8666.

Santhosh A, Kumar A, Pramanik R, Gogia A, Prasad CP,

Gupta I, Gupta N, Cheung WY, Pandey RM, Sharma

A and Batra A. Randomized double-blind, placebo

controlled study of topical diclofenac in the

prevention of hand-foot syndrome in patients

receiving capecitabine (the D-TORCH study). Trials

; 23(1):420.

Rubio-Zarapuz A, Apolo-Arenas MD, Tornero-Aguilera JF,

Parraca JA and Clemente-Suárez VJ. Comparative

efficacy of neuromodulation and structured exercise

program on pain and muscle oxygenation in

fibromyalgia patients: a randomized crossover study.

Front Physiol 2024; 15:1414100.

Murota H, Arima K, Yoshida T and Fujita H. Disease burden

and treatment satisfaction in patients with prurigo

nodularis in Japan. J Dermatol 2024; 51(2):223-233.

Blauvelt A, Eyerich K, Irvine AD, de Bruin-Weller M,

Kwatra SG, Gooderham M, Kim B, Calimlim BM,

Lee WJ, Raymundo EM, Liu Y, Ofori S, Platt AM and

Silverberg JI. More Time Spent with Clear Skin and

No Itch with Upadacitinib versus Dupilumab for

Atopic Dermatitis. Dermatol Ther (Heidelb) 2024; 7.

Piérard GE, Piérard-Franchimont C and Scheen A. Critical

assessment of diabetic xerosis. Expert Opin Med

Diagn 2013; 7(2):201-7.

Held E, Lorentzen H, Agner T and Menné T. Comparison

between visual score and erythema index

(DermaSpectrometer) in evaluation of allergic patch

tests. Skin Res Technol 1998; 4(4):188-91.

Qedair JT, Al Qurashi AA, Alamoudi S, Aga SS and Y

Hakami A. Assessment of Quality of Life (QoL) of

Colorectal Cancer Patients using QLQ-30 and QLQ

CR 29 at King Abdulaziz Medical City, Jeddah, Saudi

Arabia. Int J Surg Oncol 2022; 2022:4745631.

Clavijo M, Yévenes F, Gallardo I, Contreras AM and Santos

C. Escala de autoeficacia general: reevaluación de su

evidencia de confiabilidad y validez en Chile [The

general self-efficacy scale (GSES): Reevaluation of

its reliability and validity evidence in Chile]. Rev Med

Chil 2020;148(10):1452-1460. Spanish.

Tanaka M, Kawakami A, Maeda S, Kunisaki R and Morisky

DE. Validity and Reliability of the Japanese Version

of the Morisky Medication Adherence Scale-8 in

Patients with Ulcerative Colitis. Gastroenterol Nurs

; 44(1):31-38.

Krebs-Smith SM, Pannucci TE, Subar AF, Kirkpatrick SI,

Lerman JL, Tooze JA, Wilson MM and Reedy J.

Update of the Healthy Eating Index: HEI-2015. J

Acad Nutr Diet 2018; 118(9):1591-1602.

Krzemieniecki K, Zygulska AL, Kucharz J and Stokłosa.

Better compliance with the guidelines on hand-foot

syndrome in patients treated with capecitabine in

colorectal and breast cancer as a result of nursing

education. Przegl Lek 2016;73(7):460-4.

Son HS, Lee WY, Lee WS, Yun SH and Chun HK.

Compliance and effective management of the hand

foot syndrome in colon cancer patients receiving

capecitabine as adjuvant chemotherapy. Yonsei Med

; 50(6):796-802.

Gialaim Purcino Dos Reis FC, Menêses AG, Mazoni SR,

Pereira Silveira RCC, Diniz Dos Reis PE and Vasques

CI. Topical interventions for preventing hand-foot

syndrome resulting from antineoplastic therapy: A

scoping review. Rev Esc Enferm USP 2023; 57:

e20220107.

Ahn HR, Lee SK, Youn HJ, Yun SK and Lee IJ. Stevens

Johnson syndrome and concurrent hand foot

syndrome during treatment with capecitabine: A case

report. World J Clin Cases 2021; 9(17):4279-4284.

Santhosh A, Kumar A, Pramanik R, Gogia A, Prasad CP,

Gupta I, Gupta N, Cheung WY, Pandey RM, Sharma

A and Batra A. Randomized double-blind, placebo

controlled study of topical diclofenac in the

prevention of hand-foot syndrome in patients

receiving capecitabine (the D-TORCH study). Trials

; 23(1):420.

Park S, Sato Y, Takita Y, Tamura N, Ninomiya A, Kosugi

T, Sado M, Nakagawa A, Takahashi M, Hayashida T

and Fujisawa D. Mindfulness-Based Cognitive

Therapy for Psychological Distress, Fear of Cancer

Recurrence, Fatigue, Spiritual Well-Being, and

Quality of Life in Patients with Breast Cancer-A

Randomized Controlled Trial. J Pain Symptom

Manage 2020;60(2):381-389.

Wang X, Wang N, Zhong L, Wang S, Zheng Y, Yang B,

Zhang J, Lin Y and Wang Z. Prognostic value of

depression and anxiety on breast cancer recurrence

and mortality: a systematic review and meta-analysis

of

,203

patients.

;25(12):3186-3197.

Mol

Psychiatry

Yang Y, Sun H, Luo X, Li W, Yang F, Xu W, Ding K, Zhou

J, Liu W, Garg S, Jackson T, Chen Y and Xiang YT.

Network connectivity between fear of cancer

recurrence, anxiety, and depression in breast cancer

patients. Affect Disord 2022; 309:358-367.

Bidstrup PE, Johansen C, Kroman N, Belmonte F, Duriaud

H, Dalton SO, Andersen KG and Mertz B. Effect of a

Nurse Navigation Intervention on Mental Symptoms

in Patients with Psychological Vulnerability and

Breast Cancer: The REBECCA Randomized Clinical

Trial. JAMA Netw Open 2023; 6(6):e2319591.

Refbacks

  • There are currently no refbacks.